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Abstract
Mitochondrial potassium channels have been implicated in myocardial protection mediated through pre-/postconditioning.
Compounds that open the Ca2+- and voltage-activated potassium channel of big-conductance (BK) have a pre-conditioning-
like effect on survival of cardiomyocytes after ischemia/reperfusion injury. Recently, mitochondrial BK channels (mitoBKs) in
cardiomyocytes were implicated as infarct-limiting factors that derive directly from the KCNMA1 gene encoding for
canonical BKs usually present at the plasma membrane of cells. However, some studies challenged these cardio-protective
roles of mitoBKs. Herein, we present electrophysiological evidence for paxilline- and NS11021-sensitive BK-mediated
currents of 190 pS conductance in mitoplasts from wild-type but not BK2/2 cardiomyocytes. Transmission electron
microscopy of BK2/2 ventricular muscles fibres showed normal ultra-structures and matrix dimension, but oxidative
phosphorylation capacities at normoxia and upon re-oxygenation after anoxia were significantly attenuated in BK2/2
permeabilized cardiomyocytes. In the absence of BK, post-anoxic reactive oxygen species (ROS) production from
cardiomyocyte mitochondria was elevated indicating that mitoBK fine-tune the oxidative state at hypoxia and re-
oxygenation. Because ROS and the capacity of the myocardium for oxidative metabolism are important determinants of
cellular survival, we tested BK2/2 hearts for their response in an ex-vivo model of ischemia/reperfusion (I/R) injury. Infarct
areas, coronary flow and heart rates were not different between wild-type and BK2/2 hearts upon I/R injury in the absence
of ischemic pre-conditioning (IP), but differed upon IP. While the area of infarction comprised 2863% of the area at risk in
wild-type, it was increased to 5865% in BK2/2 hearts suggesting that BK mediates the beneficial effects of IP. These findings
suggest that cardiac BK channels are important for proper oxidative energy supply of cardiomyocytes at normoxia and upon
re-oxygenation after prolonged anoxia and that IP might indeed favor survival of the myocardium upon I/R injury in a BK-
dependent mode stemming from both mitochondrial post-anoxic ROS modulation and non-mitochondrial localizations.
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Introduction
Ischemia and post-ischemic reperfusion induce cardiac damage
[1]. Brief episodes of ischemia prior to or after the prolonged
ischemic insult have been shown to be very effective in rendering
the heart less susceptible to damage [2,3]. The infarct-reducing
effects via ischemic pre-conditioning (IP) are mediated by multiple
factors, which, at least in part, signal through potassium channels
present at the inner mitochondrial membrane (IMM) of the
cardiomyocyte (CM) [4]. Opening of mitochondrial KATP
(mitoKATP) channels has been shown to modulate mitochondrial
bioenergetics and to inhibit formation of the mitochondrial
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permeability transition pore (mPTP), which is a major determi-
nant of irreversible injury during reperfusion when oxygen is
reintroduced and the IMM potential is regenerated [5–8].
However, their cardio-protective roles in the mitochondrion have
also been questioned [9]. In addition to mitoKATP, intracellular
Ca2+-activated potassium channels of big-conductance (BK) [10]
first recognized in a human glioma cell line [11] have been
identified in mouse CMs [12] at the IMM (mitoBK) [13–15], but
not in the sarcolemma [15,16]. Experiments using isolated
ventricular CMs from rat and guinea pig hearts suggest that
opening of mitoBK prevents mitochondrial matrix Ca2+ overload
and attenuates reactive oxygen species (ROS) production,
pathological hallmarks for mPTP formation and cell death, upon
reperfusion of the heart [16–18]. MitoBK activation may thus
confer cardio-protection in a manner similar to but independent of
mitoKATP [19], but to this end its function at physiological
conditions is unclear. Physiological and pharmacological proper-
ties of mitoBK channels purified from cardiac mitochondria
indicate that their properties are comparable to plasma membrane
BK channels [15,20–23]. Importantly, BK channel openers
(NS1619 and NS11021) applied at the onset of reperfusion are
cardio-protective independent of changes in KATP activity or
hemodynamic alterations [24–26]. Cardio-protection was sensitive
to the BK blocker paxilline and could be observed for 24 hours
upon pretreatment [24]. Additionally, accessory b1-subunits of BK
that modulate kinetics and Ca2+-sensitivity of the channel were
identified in mitochondria of CMs and their knock-down
abolished infarct-limiting effects of the phosphodiesterase-5
inhibitor sildenafil [13]. A combination of yeast two-hybrid and
immune-cytochemical assays provided further evidence for an
IMM complex enclosing BK b1-subunits and cytochrome c
oxidase I indicating direct recruitment of multimeric BK channel
proteins to the oxidative phosphorylation machinery [23]. A
number of additional studies have reported the involvement of BK
in the signaling pathway of agents leading to cardio-protection.
This list includes among others adenosine [27], k-opoid receptor
agonist [28], b-estradiol [23], and desflurane [29,30]. These agents
protected the heart from I/R injuries when applied prior to
ischemia, and the protection was attenuated by co-administration
of toxins, such as paxilline, inhibiting BK, thereby strongly
supporting the notion that pro-survival pathways promote BK
activity. However, these conclusions have been recently challenged
since the widely used BK opener NS1619 might have additional
effects unrelated to mitoBK channels [31–33]. Furthermore, IP or
anesthetic preconditioning (APC) protocols efficiently protected
BK-negative hearts from I/R injury [34], although, beneficial
effects of APC were sensitive to paxilline in the absence of BK.
Finally, it has been suggested that protection via BK and NS1619
at I/R is a function of intrinsic cardiac neurons [35], but it
remained largely elusive how the protective signals would be
transmitted to the CM.
In contrast, in the presented study, we show immune blots
supported by electrophysiological recordings that provide evidence
for a paxilline- and NS11021-sensitive mitoBK channel at the
IMM of CM. Ablation of KCNMA1 encoding the BK channel
protein [36] resulted in elevated ROS release of CM mitochondria
upon anoxia and reoxygenation and severe bioenergetic defects
reflected by a reduced oxidative phosphorylation capacity
(OXPHOS). Importantly, OXPHOS capacities of BK-deficient
ventricular muscle fibres were attenuated at physiological/
normoxic conditions and upon re-oxygenation after prolonged
anoxia, whereas no gross abnormalities in mitochondrial ultra-
structures i.e. matrix volume were detectable. Since a reduced
bioenergetic reserve of CM mitochondria and high ROS at O2-
reintroduction should render the heart more susceptible to
damages, and IP might preserve ATP-synthesizing enzyme
activities in the electron transport chain at I/R we studied
whether BK2/2 hearts subjected to I/R injury would be protected
by established IP paradigms. Together, our data suggest that IP
requires mitoBK channels (and possibly non-mitochondrial
channels present in e.g. the vasculature) to 1) enable a proper
oxidative phosphorylation activity of mitochondria allowing ADP-
stimulated respiration upon oxygen reintroduction to the myocar-
dium, and 2) limit the I/R injuries to the myocardium possibly via
dampening post-anoxic ROS generation.
Research Design and Methods
Experimental animals and ethic statements
All animals were bred in the animal facility of the Institute of
Pharmacy, University of Tübingen and had free access to tap
water and standard chow. Maintenance and procedures were
conducted according to the local government’s committee on
animal care and welfare in Tübingen, Copenhagen and Munich.
The study conformed with the European Community Guidelines
for the Care and Use of Experimental Animals, and was approved
by the Animal Ethics Screening Committee of the Panum Institute
(clearance number: 2011/0015-6221). BK channel knockout mice
(BK2/2) that carry a global inactivation of the KCNMA1 gene
were described earlier [36,37]. For experiments organs, cells or
organelles derived from BK2/2 animals were compared to wild-
type mice (BK+/+) from the same litters on a mixed SV129/
C57BL/6 (F1) genetic background since an efficient ischemic pre-
conditioning of the SV129/C57BL/6 strain has been reported
earlier [38].
Purification of mitochondria from cardiac myocytes and
immuno-blotting
The isolation of adult cardiomyocytes from BK+/+ and BK2/2
mouse hearts was performed as described previously [39] by a
modified protocol of the Alliance for Cellular Signaling (AfCS)
(AfCS procedure protocol PP00000125). Upon perfusion the
hearts were minced into small pieces and myocytes were liberated
by gently applying mechanical turbulence. A small fraction of cells
was plated in 24-well format on laminin coated glass cover-slips to
check for the quality and purity of the purification. The content of
healthy rod-shaped CMs was usually .95%. Purifications with a
lower mycoyte content or quality were not further processed.
Mitochondria enriched fractions were generated according to
Frezza et al. 2007 in less than 100 min from adult primary CMs
[40]. In brief, the cells were washed and homogenized using a
glass-teflon pestle based tissue-grinding system in IBc buffer
(10 mmol/lTris–MOPS, 1 mmol/l EGTA/Tris, 0.2 M sucrose,
pH 7.4) at 4uC. Cell debris and mitochondria were separated by
three subsequent centrifugation steps at 700 g, 3000 g and 7000 g
at 4uC for 10 min each, and then resuspended in a final volume of
30 ml in SDS lysis buffer. Western Blot analyses were performed
only on freshly isolated mitochondrial lysates within 48 hours after
the purification. For all experiments myocytes/mitochondria
purified from 2–3 hearts per genotype were pooled.
Western Blot was performed as described previously [41]. The
primary antibodies used were specific for BK (Alomone, #APC-
107 (dilution 1:250) and #APC-021 (dilution 1:200)), COX4 (Cell
Signaling, #4844 (dilution 1:1000)) and hsp60 (Santa Cruz, #H-
300 (dilution 1:200)).
KCNMA1/mitoBKs at I/R
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Electrophysiological recordings from CM mitoplasts
Vital CMs were prepared by enzymatic digestion of mouse
heart via retrograde perfusion through the aorta as previously
described [42]. CM mitochondria were isolated [40] for prepa-
ration of mitoplasts by osmotic swelling in hypotone solution for
7 min. Subsequently isotonicity was restored [11]. Mitoplasts were
freshly prepared directly before experiments, stored on ice and
used within 2 h. Electrophysiological recordings were carried out
using an internal solution containing (in mmol/L) 60 KF, 60 K-
gluconate, 10 KCl, 10 HEPES, 200 sorbitol and an external
solution containing (in mmol/L) 10 K-gluconate, 10 HEPES, 1
Ca-gluconate, 260 sorbitol. 10 mmol/l ruthenium red, 50 mmol/l
propranolol, 10 mmol/l bepridil and 10 mmol/l cyclosporin A
were freshly prepared and added to the internal and external
solutions in order to block mitochondrial Ca2+ uniporter, inner
membrane anion channels (IMAC), Slo2.2 and mPTP, respec-
tively. Thereby, the identity of our cardiomyocyte mitoplast
preparations could be confirmed since mitochondria-specific
IMAC activity (data not shown) was reportedly blocked by
propranolol [43]. Patch clamp experiments were performed using
a Port-a-Patch system (Nanion) and a HEKA EPC-10 amplifier.
NPC-1 chips with a resistance of 10–15 MV (diameter of the holes
,1 mm) and an external salt bridge (3 mol/l KCl, 3% agarose) as
ground reference were used. All recordings where done in whole
mitoplast mode (capacitance of about 1 pF). Voltage pulses of
2 sec to 80 mV from a holding potential of 250 mV were applied
every 5 sec. Each experiment consisted of three phases of 3 min
duration. After the first control phase, NS11021 (10 mmol/l) was
added to the external solution to ensure a significant increase in
the open probability of BK [44], and 3 min later exchanged by an
external solution containing paxilline (100 nmol/l).
Different amplitudes of single channel conductance were
classified in each phase and experiment, and their frequency was
calculated and normalized to the number of experiments. Multiple
occurrences during one phase were counted as one.
High-resolution respirometry on permeabilized
myocardial muscle and soleus skeletal muscles
Surgically extracted hearts from BK+/+ and BK2/2 mice were
prepared based on a previously published protocol [45]. In brief,
hearts were placed in ice-cold preservation solution (BIOPS)
containing 10 mmol/l CaK2EGTA buffer, 7.23 mmol/l
K2EGTA buffer, 0.1 mmol/l free calcium, 20 mmol/l imidazole,
20 mmol/l taurine, 50 mmol/l 2-(N-Morpholino) ethanesulfonic
acid hydrate (K-MES), 0.5 mmol/l dithiothreitol (DTT),
6.56 mmol/l MgCl2N6H2O, 5.77 mmol/l ATP, and 15 mmol/l
phosphocreatine (pH 7.1). The left ventricle was sectioned and
dissected free from surrounding connective tissue with needle
forceps and 2 equal portions of ,1–2 mg were isolated for
mitochondrial respirometry. Prior to permeabilization the myo-
cardial muscle bundles were gently dissected with two pairs of
sharp forceps to achieve a high degree of fibre separation verified
microscopically and by pallor. Chemical permeabilization of the
sarcolemma was undertaken by incubation of the muscle fibre
bundles with 20 ml of saponin (5 mg/ml) in 2 mL of BIOPS and
stirred on ice for 20 min. Permeabilized samples were then rinsed
with a mitochondrial respiration medium containing 0.5 mmol/l
EGTA, 3 mmol/l MgCl2N6H2O, 60 mmol/l K-lactobionate,
20 mmol/l taurine, 10 mmol/l KH2P04, 20 mmol/l HEPES,
110 mmol/l sucrose, and 1 g/l bovine serum albumin (pH 7.1).
Immediately after rinsing, the left ventricular muscle bundles were
blotted and measured for wet weight in a balance controlled for
constant relative humidity, and each sample was then placed into a
single chamber of the respirometer (Oxygraph, Oroboros Instru-
ments, Innsbruck, Austria) containing mitochondrial medium
(MiR05). Instrumental calibrations were performed to correct for
back-diffusion of oxygen into the chamber, leak from the exterior,
and sensor oxygen consumption. Oxygen flux was resolved by
software allowing nonlinear changes in the negative time
derivative of the oxygen concentration signal. Respirometry was
performed at a chamber temperature of 37uC. Malate (2 mmol/l)
was added to the chamber to prime the tricarboxylacid cycle and
to achieve resting respiration in the absence of adenylates.
Subsequent substrate titrations tested ADP-stimulated mitochon-
drial respiration catalyzing sequential redox reactions primarily
coupled to the production of ATP via ATP synthetase (complex
V). OXPHOS capacity of NADH dehydrogenase (Complex I
(PCI)) was achieved with the addition of glutamate (10 mmol/l)
followed by ADP (5 mmol/l). Maximal respiration and OXPHOS
capacity (PCI+II) was stimulated with the addition of succinate
(10 mmol/l) through complex II i.e. succinate dehydrogenase. To
examine the effect of hypoxia/anoxia on the intrinsic function and
viability of mitochondria during recovery from anoxia, the [O2] in
the respirometer was reduced to zero by addition of N2 to the
chambers. A first anoxia exposure of 5 min approximating the in-
vivo ‘pre-conditioning’ condition was followed by re-oxygenation,
and a second anoxia exposure of 60 min was applied and again
followed by re-oxygenation. Subsequently, the integrity of the
inner mitochondrial membrane was tested by titration of
cytochrome c (10 mmol/l). Antimycin A (2.5 mmol/l) was then
added to terminate respiration by inhibiting cytochrome bc1
complex (complex III), allowing for the determination of residual
oxygen consumption in the oxygraph chamber. The maximal
oxidative rate of cytochrome c oxidase (complex IV, or COX), the
terminal respiratory chain complex that catalyzes the reduction of
oxygen to water at cytochrome aa3 was assessed by addition of the
redox substrates ascorbate (2 mmol/l) and N,N,N’,N’-tetramethyl-
1,4-benzenediamine dihydrochloride (TMPD 5 mmol/l). Finally,
to quantify and account for respiration due to auto-oxidation of
TMPD, sodium azide (100 mmol/l) was added to the chamber.
For O2-respirometry of skeletal muscles a small portion of the
biopsied soleus (,2–3 mg) was placed into BIOPS medium (as
above) followed by fibre separation and permeabilization with
saponin. The muscle bundles were then rinsed, blotted and
measured for wet weight in a balance. Muscle bundles were then
transferred immediately into the respirometer containing the
respiration medium (as above) at a chamber temperature of 37uC.
All measurements were performed as described in detail for
cardiac fibres, however instead of 60 min anoxia was maintained
for 90 min with 100% nitrogen.
Electron microscopy
The mice were pre-anaesthetised with inhalation of Halothane
3% (Halocarbon Laboratories, River Edge, NJ, USA). Anaesthesia
was induced by doses of a 9:1 mixture of Ketamine 25 mg/ml
(Pfizer, Ballerup, Denmark) 90 mg/kg and Xylazine 20 mg/ml
(Bayer, Leverkusen, Germany) 10 mg/kg. Vascular perfusion
through the left ventricle of the heart was performed with 2%
v/v glutaraldehyde in 0.05 M sodium phosphate buffer (pH 7.2)
for 5 min. Briefly, following thoracotomy, a small incision was
made of the apex of the heart, followed by insertion of a narrow
cannula, which was clamped close to the apex. Following fixation
the hearts were stored in the same fixative. Following isolation of
suitable left ventricle specimen blocks proximal to the site of
cannula insertion, the samples were rinsed three times in 0.15 M
sodium cacodylate buffer (pH 7.2) and subsequently postfixed in
1% w/v OsO4 in 0.12 M sodium cacodylate buffer (pH 7.2) for
2 h. The specimens were dehydrated in graded series of ethanol,
KCNMA1/mitoBKs at I/R
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transferred to propylene oxide and embedded in Epon according
to standard procedures. Sections, approximately 80 nm thick,
were cut with a Reichert-Jung Ultracut E microtome and collected
on copper grids with Formvar supporting membranes, stained
with uranyl acetate and lead citrate, and subsequently examined
with a Philips CM 100 TEM (Philips, Eindhoven, The Nether-
lands), operated at an accelerating voltage of 80 kV. Digital images
were recorded an OSIS Veleta digital slow scan 2 k62 k CCD
camera and the ITEM software package.
Measurement of reactive oxygen species production
from isolated cardiac mitochondria
Hearts were removed as described above and placed in ice-cold
isolation medium containing: sucrose (100 mmol/l), KCl
(100 mmol/l), Tris-HCl (50 mmol/l), KH2PO4 (1 mmol/l),
EGTA (100 mmol/l), BSA (0.1%) adjusted to pH 7.4. Mitochon-
drial isolation procedures were initiated within 5 hours of excision.
Hearts were dissected free of connective tissue and fat, weighed
and cut with small scissors into fine pieces followed by a three-step
differential centrifugation procedure. In the initial isolation step
bacterial protease (0.2 mgNml21) was added to the media. The
final pellet was resuspended in preservation solution containing
EGTA (0.5 mmol/l), MgCl2 (6.3 mmol/l), K-lactobionate
(60 mmol/l), taurine (20 mmol/l), KH2PO4 (10 mmol/l), HEPES
(20 mmol/l), sucrose (110 mmol/l), BSA (1 g/l), histidine
(20 mmol/l), glutathione (3 mmol/l), leupeptine (1 mmol/l), glu-
tamate (2 mmol/l), malate (2 mmol/l), Mg-ATP (2 mmol/l).
Mitochondrial ROS production and respiration were measured
simultaneously using an Oroboros O2k oxygraph equipped with a
flourometric sensor [46]. ROS production was detected using
horseradish peroxidase (10 U) and Amplex Ultrared (20 mmol/l
final concentration, Molecular Probes Invitrogen) added to each
chamber. With a 3 ml mitochondrial suspension in the respirom-
eter, the substrates pyruvate (5 mmol/l), malate (2 mmol/l), and
succinate (10 mmol/l) were added to elicit ‘leak respiration’ and
ROS production was recorded after stabilization of the signal.
Subsequently, ADP (2 mmol/l) was added and oxygen in the
chamber was set to ,3 kPa using nitrogen gas. The chamber was
closed and the ROS signal at ,1.5–2 kPa oxygen was termed
‘‘pre-anoxia’’. Mitochondria were then allowed to consume all
oxygen in the chamber and then remained in anoxia for
20 minutes, whereupon oxygen was allowed back into the
chamber and ROS-production was again recorded. The ROS
signal was calibrated, adjusted for non-biological drift and
quantified in connection with every experiment using a multiple-
point standard curve with HCl stabilized stocks of H2O2. Oxygen
consumption was recorded simultaneously using the same
principles as with the permeabilized fibers.
Isolated mouse heart Langendorff preparations
Animals were anesthetized subcutaneously by a mixture of
midazolam (12.5 mg/kg), fluanisone (25 mg/kg), and fentanyl
citrate (0.8 mg/kg), and anticoagulated by intraperitoneal injec-
tion of heparin (1,000 IE/kg). After induction of surgical
anesthesia, the heart was excised through a median sternotomy,
weighted, placed in ice-cold modified Krebs-Henseleit (KH)
solution (in mmol/L): NaCl (118.0), KCl (4.7), CaCl2 (2.5),
KH2PO4 (1.2), Mg2SO4 (1.2), Na- pyruvate (2.0), NaHCO3 (25),
and glucose (11.0) at pH 7.4–7.5 and mounted on the perfusion
apparatus (model IH-SR, Hugo Sachs Elektronik-Harvard Appa-
ratus GmbH, Germany) with the time delay ,4 min. In order to
facilitate coronary effluent drainage, a small incision was made at
the root of the pulmonary artery. Perfusion of the heart was
performed in the Langendorff mode and at constant pressure of
80 mmHg with continuously warmed (37uC), aerated (95% O2
with 5% CO2) and filtered (in-line 0.45 mm Sterivex-HV filter)
KH solution. Throughout the experiment, the heart was kept in
the enclosed water-jacketed chamber with ambient temperature
maintained at 37uC60.7 as monitored by a laboratory mercury
thermometer. Temperature of the perfusion solution (3760.3uC)
was continuously measured by the thermocouple microprobe
placed at the entry into the aortic cannula. Coronary flow rate was
recorded via an ultrasonic flow meter probe integrated in the
aortic block placed above the heart. The heart was allowed to beat
spontaneously and its electrical activity was monitored by
epicardial ECG recording obtained via two Ag/AgCl electrodes
positioned on the right atrium and the apex. Aortic pressure,
coronary flow, ECG and perfusate temperature were continuously
recorded using the 16-channel Powerlab system (ADInstruments,
Oxford, UK) and LabChart 7 software. Hearts were randomized
into the control (CTRL) group and ischemic preconditioning (IP)
group. CTRL group was subjected to 45 min equilibration
followed by 33 min global zero-flow ischemia and 60 min
reperfusion. Experimental animals in the IP group were subjected
to 25 min equilibration period then to 2 cycles of 5 min global
zero-flow ischemia and 5 min reperfusion, followed by 33 min
ischemia and 60 min reperfusion. Seven hearts were excluded
from the study as they did not fulfill one of the following inclusion
criteria: (i) time delay to cannulation ,4 min, (ii) basal coronary
flow ,5 mL/min (indicating absence of aortic damages), (iii) no
sustained arrhythmia and heart rate .300 bpm at the end of
equilibration period.
Measurements of infarct area
After the completion of reperfusion, hearts were immediately
frozen at 280uC for 10 minutes and then cut into 5–6 transverse
slices and stained in 1% TTC (2,3,5-triphenyl-tetrazolium chloride
in phosphate buffer (88 mmol/l Na2HPO4, 1.8 mmol/l
NaH2PO4, pH = 7.4) for 15 min in 37uC. TTC was then replaced
with 4% formaline for at least 16 h before each individual slice was
blotted, weighted and scanned at the resolution of 1200 dpi
(Canon scanner, LIDE70, Denmark). Determination of infarct size
was performed as previously described [26]. Briefly, the total areas
of individual slices, areas at risk (AARn), and areas of infarction
(AIn) were measured by planimetry (Image J 2.0 software, NIH,
USA) and infarct size was calculated as % of total cardiac mass
(AAR) and determined as the weighted mean of individual slice
values: (AIn/AARn)6(Wn/Wtotal), where Wn is the weight of the
respective section (n) and Wtotal is the sum weight of all slices.
Quantification of infarct size was performed in a blinded manner
in respect to genotype and experimental protocol. Hearts from
both sex were pooled since their susceptibility to the ischemic
insult per se did not differ and they showed an equal responses to
the IP (gender-related data not shown).
Statistics
Data are expressed as mean 6 SEM. Electrophysiological
results of BK+/+ were tested by a one-way ANOVA, and
compared to BK2/2 by a two-way ANOVA (Fig. 1). Electro-
physiological experiments were treated as Bernoulli experiments.
The effect of genotype on respiration and ROS production was
evaluated using un-paired t-test (Fig. 2, Fig. 3 and Figure S3 in
File S1) and a Two-way analysis of variance (ANOVA) followed by
a Tukey’s multiple comparison test (Fig. 2B). Infarct size was
compared using One-way analysis of variance (ANOVA) test
followed by a Turkey’s multiple comparison test (Fig. 4B).
Morphometric characteristic and basal coronary flow and heart
rate in 4 experimental groups was analyzed using One-way
KCNMA1/mitoBKs at I/R
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ANOVA test (Table S1 in File S1). Effects of the experimental
protocols and genotypes on post-ischemic coronary flow and heart
rate were compared using Two-way ANOVA followed by
Bonferroni post-hoc test (Fig. 4C and D). Total reactive hyperemic
volume was compared using an un-paired t-test (Figure S4 in File
S1). Errors estimate was done by calculating the variability across
different animals. Probability value of P,0.05 was considered
significant.
Results
We first confirmed that the BK channel is detectable in
mitochondrial protein fractions isolated from BK wild-type
Figure 1. Paxilline and NS11021 sensitive mitoBK channels give rise to a 190 pS conductance, which is absent in BK-negative
mitoplasts. (A1+2) Expression analysis of BK channels mitochondrial protein fractions of adult heart (A1) and cardiac myocytes (A2) from BK2/2 and
litter-mate BK+/+ mice. Immune-reactive bands corresponding to the predicted molecular weight (approx. 120 kDa) of BK channels were detected
only in mitochondrial protein fractions derived from BK+/+ hearts and cardiac myocytes (red arrow), whereas mitochondrial lysates from BK2/2 tissues
remained BK-negative. By identifying cytochrome c oxidase IV (COX IV) or heat shock protein 60 (hsp60) equal loading of the samples was confirmed.
A fluorescent protein marker was used to estimate the sizes of the respective proteins (not shown). (B) Four different conductances were observed in
mitoplasts from cardiomyocytes in a voltage step protocol with 2 seconds at +80 mV followed by 3 seconds at holding potential (250 mV). Internal
to external potassium ratio was 130:10 mmol/l during the experiment. The magnitude of the occurring conductances under these conditions was
calculated to approx. 370, 190, 120 and 60 pS. The figure displays individual representative traces of different patches which show a specific activity at
the recorded time. Arrows indicate open state. (C) The relative frequency over 3 minutes of recording of the 190 pS (resembling BK K+-currents)
conductance decreased from 29%68% in BK+/+ mice to 0% in BK2/2 mice. NS11021 increased the incidence of the 190 pS conductance to 4163%,
whereas the BK opener had no effect on BK-negative mitoplasts and paxilline reduced the incidence to 665% in BK+/+ mitoplasts (number of single
measurements was n = 17 for BK+/+ and n = 23 for BK2/2, number of mitoplasts preparations was four for each group). Statistical analyses were
performed on BK+/+ mitoplasts recorded in the untreated (basal) versus treated states (paxilline or NS11021). Additionally, all three conditions (basal,
paxilline, NS11021) were tested for significant differences between the two genotypes (*P,0.05, **P,0.01). (D) Single channel analysis of an
individual trace of a 190 pS conductance. The histogram with Gaussian fit results in a conductance of 192 pS. Additionally, slope conductance was
determined by linear fit of current amplitude versus voltage confirming a conductance of 190 pS. (E) When assuming an easy two state model open
probability can be calculated by idealization of channel openings and analysis of dwell times. This results in an open probability of 0.79 at 80 mV.
doi:10.1371/journal.pone.0103402.g001
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(BK+/+) hearts and CMs, whereas mitochondrial fractions derived
from the respective BK2/2 cells/organs remained BK negative
(Fig. 1A). As compared to control tissues (e.g. cerebellum (not
shown)) BK protein expression levels in heart and CM mitochon-
dria were very low, however, the molecular weight of the immuno-
positive bands indicate that mitoBK channels have a similar
molecular identity of approx. 120 kDa as canonical BKs usually
present in the plasma membrane of cells. To examine the
electrophysiological and pharmacological properties of the mi-
toBK we studied mitoplasts, generated by osmotic swelling. The
quality of these purifications i.e. the strongly availability of
contaminant mitochondrial outer membranes was confirmed by
high magnification microscopy (Figure S1A in File S1). Under the
given experimental conditions (s. Methods) we observed ionic
conductances of 4 magnitudes in BK+/+ mitoplasts with a different
relative frequency during 9 minutes of recording: ,60 pS (35%),
,120 pS (80%), ,190 pS (55%) and ,370 pS (15%) (Fig. 1B).
Importantly, only the ,190 pS conductance was absent from
BK2/2 mitoplasts, whereas all other magnitudes were still present.
Therefore, subsequent analyses focused on the ,190 pS conduc-
tance. We separated the patch-clamp recordings into 3 identical
intervals of 3 min duration. After the first control phase
resembling 3 min of baseline measurement, NS11021 (10 mmol/
l) was applied with the external solution, which was exchanged by
paxilline (100 nmol/l in external solution) 3 min later (Fig. 1C).
NS11021 increased the relative frequency of the ,190 pS
conductance by 12%, whereas paxilline superfusion had the
opposite effect reducing the relative frequency of the respective
conductance to 6% in BK+/+ mitoplasts. In BK negative
mitochondria neither NS11021 nor paxilline had an effect strongly
supporting the notion that mitoBK channels are the product of the
KCNMA1 gene targeted by our global BK channel knockout
strategy [36]. For a better characterization of the mitoBK we
examined phases of single channel activity. These in-depth
analyses of representative traces revealed a slope conductance of
190 pS and an open probability of 0.79 at +80 mV for the murine
mitoBK (Fig. 1D and E). Importantly, these data complement very
recent findings by Singh and co-workers [47], and together
Figure 2. Mitochondrial respiratory responses in mouse left heart ventricular fibres. O2-consumption of permeabilized BK
+/+ fibres (blue
bars) and fibres isolated from BK2/2 hearts (red bars) were measured by applying an in vitro model of I/R at normoxia and reo-xygenation (both at
21% O2) upon 60 min of anoxia (by a N2 gassing system). For a representative original recording trace please refer to Figure S2 in File S1. (A) Coupled
state 3 respiratory rate (OXPHOS) with complex I (CI) substrates malate (2 mmol/l) and glutamate (10 mmol/l) in the presence of ADP (5 mmol/l). (B)
Cumulative OXPHOS of CI and II upon subsequent addition of succinate (10 mmol/l) to (A) for a supply of electrons to complex II (CII). OXPHOS of CI
and II after 5 min (OXPHOS5) and after 60 min (OXPHOS60) of anoxia are shown. (C) Ratio of respiration upon addition of cytochrome c (CYTC) 5 min
after 60 min anoxia compared to steady state respiratory flux rate before anoxia as a test for intactness of the IMM. (D) Isolated activity of complex IV
(cytochrome c oxidase (COX)) with redox substrates ascorbate (2 mmol/l) and TMPD (5 mmol/l) in the presence of complex III blocker Antimycin A
(2 mmol/l). (E) Ratio of OXPHOS to COX activity under fully oxygenated conditions showing loss of COX excess capacity in BK2/2 as the ratio
approaches 1.0 revealing an insufficient reserve capacity to produce energy in mitoBK-deficient fibres. Data are mean 6 SEM with n = 6 for BK+/+ and
n = 9 for BK2/2 with ns = non-significant and **P,0.01 significantly different compared to BK+/+ (Fig. 2A, C, D two-tailed paired t-test). *P,0.05, **P,
0.01, significantly different compared to BK+/+ within the respective condition (Fig. 2B).
doi:10.1371/journal.pone.0103402.g002
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provide strong evidence for mitoBK channels encoded by the
murine KCNMA1 gene in cardiac myocytes.
We next performed high-resolution respirometry measurements on
permeabilized myocardial muscle fibres to test whether the ablation of
mitoBK has any consequences for mitochondrial function at normoxia
or anoxia with re-oxygenation. A representative trace is shown in
Figure S2 in File S1. Mitochondrial OXPHOS capacity for the
complex I (CI) substrate glutamate was reduced in BK2/2 (Fig. 2A)
compared to BK+/+ fibres (10967 vs. 149612 pmol?sec21?m g21, P,
0.05), as was the maximal mitochondrial flux rate with convergent
electron supply through CI+II (329635 vs. 483657 pmol?-
sec21?mg21, P,0.05, Fig. 2B). Accordingly, the substrate control
ratio (CI/CI+II) was similar for BK2/2 (0.3560.01) and BK+/+
(0.3460.03) indicating a proportional down-regulation of coupled
respiration of the electron transfer system (ETS). Next, we tested the
response of the fibre preparations to different levels of oxygenation
in vitro. Following the 5 min period of anoxia, mitochondrial
respiration rate with re-oxygenation recovered in both BK+/+ (from
483657 to 462651 pmol?sec21?mg21) and BK2/2 (329635 to
316631 pmol?sec21?mg21, Fig. 2B) fibres to almost the same level as
the pre-anoxia level. Following a subsequent period of 60 min of
anoxia mitochondrial respiration was 15% lower in BK+/+ and 19% in
BK2/2 fibres. Although this did not reach significance res-
piration rates remained lower in BK2/2 compared to BK+/+
following 5 and 60 min of anoxia (p,0.05, Fig. 2B) in BK+/+
and BK2/2 fibres as compared to pre-anoxia levels, respective-
ly. A decline in the OXPHOS recovery is indicative of either
anoxic fragility, disruption of the membrane potential and/or
diminished activity of the IMM respiratory complexes. Since no
additive responses to subsequent addition of external cyto-
chrome c were detected in either groups (Fig. 2C) we conclude
that the OMM remained intact following the anoxic stimuli.
However, the isolated respiratory flux rate of cytochrome c
oxidase (COX) [48] (747699 pmol?sec21?mg21, P,0.05,
Fig. 2D) was higher than total OXPHOS capacity in BK+/+
fibres (OXPHOS to COX ratio 0.6660.04, Fig. 2E) observed
under normoxic conditions, whereas in the BK2/2 no excess
capacity of COX (375666 pmol?sec21?mg21, P = 0.48, Fig. 2D)
over OXPHOS (OXPHOS to COX ratio 0.9660.06, Fig. 2E)
could be observed indicating a loss of the bioenergetic reserve of
respiration coupled to ATP production. As an ultimate proof
that the changes observed in mitochondrial functions resulted
from a distorted activity of the respiratory chain enzymes upon
mitoBK ablation and not due to structural changes of the CM
Figure 3. Simultaneous ROS production and respiration measurements of isolated BK+/+ and BK2/2 mitochondria. Oxygen
consumption and ROS are determined by using an oxygraph with fluorometric detection of H2O2 production as H2O2 production expressed relative
to oxygen consumption (pmolNpmol21). (A) ‘‘Leak’’ is the respiratory state were cardiomyocyte mitochondria are exposed to the substrates pyruvate
(5 mM), malate (2 mM) and succinate (10 mM) without ADP. The resulting increase in substrate-induced membrane potential enhanced ROS
production of BK+/+ and BK2/2 mitochondria to a similar extent. (B) Respiration was stimulated by ADP (2 mM) and oxygen pressure was lowered
from ,21.2 kPa to ,3 kPa. ROS production at peak respiration rate before O2 limits respiration (prior to the O2-dependent hyperbolic decline in
respiration that occurs below 3 kPa) was termed ‘‘preanoxia’’, and again there was no difference between BK+/+ and BK2/2 mitochondria. (C) After
20 minutes of complete anoxia, the chambers were re-oxygenated to ,3 kPa and ROS production was quantified as ‘‘postanoxia’’. (D) Post-anoxic
related to pre-anoxic ROS production of BK+/+ mitochondria was significantly lower than in BK2/2 mitochondria. Data are mean 6 SEM, n = 3 to 4 per
experiment and genotype. **P,0.01 significantly different compared to BK+/+ (two-tailed paired t-test).
doi:10.1371/journal.pone.0103402.g003
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mitochondriome, we performed transmission electron microsco-
py (TEM) analyses of BK+/+ and BK2/2 ventricle fibres (Figure
S1B in File S1). TEM [49] images from mitochondria in the
rested, unstressed state indicate neither apparent down-regula-
tion of mitochondrial volume nor distinct morphological
changes across multiple sections. Indeed, the TEM revealed a
highly dense distribution of mitochondria in fibres from both
genotypes, evidence of mega-mitochondria, fusion and a vast
network of interfibrillar and subsarcollemal mitochondria with
no signs of cristae disruption, or inter-membrane swelling
Figure 4. Loss of myocardial ischemic preconditioning in BK2/2 hearts. (A) Schematic illustration of the protocols used for the assessment of
I/R injury in isolated, perfused hearts of BK+/+ and BK2/2 mice. CTRL indicates a control protocol with 33 min global zero-flow ischemia followed by
60 min reperfusion and IP denotes an ischemic preconditioning protocol consisting of 2 extra cycles of 5 min ischemia and 5 min reperfusion
preceding the global ischemic insult. (B) Effects of CTRL and IP protocol on post-ischemic coronary flow rate normalized to heart weight during
reperfusion (upper), with each point depicting mean values 6 SEM of the preceding 5 min recording. Coronary flow is significantly different as tested
by Two-way ANOVA. Lower panel shows that IP improves coronary flow in the BK+/+ but not in the BK2/2 group as evidenced by increased perfusate
volume at reperfusion (area under the curve from the upper panel) at the time interval from 30 to 45 min and from 45 min to 60 min (ns = non-
significant, *P,0.05 for CTRL BK+/+ versus IP BK+/+; Two-way ANOVA followed by a Bonferroni post-hoc test). (C) Effects of CTRL and IP protocol on
post-ischemic heart rate in BK+/+ and BK2/2 group. Each point depicts mean values 6 SEM of the 15 min interval recording excluding rare
extrasystolic beats. Due to multiple sustained arrhythmias in the first 30 min of reperfusion, heart rate could not be reliably measured at the interval
from 0–30 min (no differences between genotypes). Heart rate of BK+/+ hearts is lower in the IP than in the CTRL group (*P,0.05 CTRL BK+/+ versus IP
BK+/+; Two-way ANOVA followed by a Bonferroni post-hoc test). (D) Effects of CTRL and IP protocol on infarct size in BK+/+ and BK2/2 groups (upper
panel). Infarct size is comparable between BK+/+ and BK2/2 hearts in the CTRL group, but IP failed to protect BK2/2 hearts resulting in smaller infarct
sizes of BK+/+ hearts (**P,0.01; One-way ANOVA followed by Tukey’s multiple comparison test). All values are means 6 SEM. Data from male and
female BK+/+ and accordingly BK2/2 hearts were pooled since sub-group analyses revealed that differences in the infarct sizes did not depend on sex.
Lower panels demonstrate representative images of myocardial sections stained with tetrazolium chloride where red color indicates viable tissue and
un-stained pale color demarcates infarcted areas.
doi:10.1371/journal.pone.0103402.g004
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(Figure S1B in File S1). Extending from these observations the
functional marker of a higher OXPHOS to COX respiration
ratio in mitoBK-deficient fibres (0.9 vs. 0.65) indicates
dysregulated mitochondrial function at normoxia and re-
oxygenation linked to a loss of excess capacity of COX i.e.
independent of structural deficits such as density or volume of
the mitochondria (Figure S1B in File S1). Since OXPHOS
capacities are to some extent diminished in both BK+/+ and
BK2/2 fibres upon anoxia (Fig. 2B), we conclude that the BK
ablation i.e. absence of mitoBK per se does not affect the
OXPHOS response to a limited supply with O2. Further, our
in vitro O2-respiration experiments may imply that protective
factors need to be released (possibly outside the CM) to signal to
the CM mitochondrion for establishing mitoBK-dependent
cardio-protection. To test whether this signalling model applies
to all types of striated muscles or if the observed effects are
specific for the myocardium we performed a related set of
respirometry measurements on BK+/+ and BK2/2 soleus muscle
fibre bundles (Figure S3 in File S1). Collectively, these analyses
reveal no differences between the two genotypes indicating that
mitochondrial bioenergetics upon BK ablation are only affecting
the heart.
In order to mechanistically substantiate the role of the
endogenous mitoBK we next recorded OXPHOS and ROS
production simultaneously from isolated cardiac mitochondria.
After 20 minutes of complete anoxia ROS production (normalized
to OXPHOS capacity) at fully oxygenated conditions or upon
deprivation of ADP were not different between BK+/+ and BK2/2
mitochondria (Fig. 3A and B). However, post-anoxic ROS
generation rates from BK2/2 mitochondria were elevated
(Fig. 3C) and this difference reached significance when comparing
pre-/post-anoxic ROS/OXPHOS ratios of both genotypes
(Fig. 3D).
Since elevated ROS at re-oxygenation and a loss of bioenergetic
reserves for coupled respiration and ATP production renders CMs
less capable of generating sufficient energy supply for contractile
and homeostatic function under high loading conditions or
ischemia we addressed the role of cardiac BK channels for
cardio-protection in the well-established isolated, beating heart
model [26].
In a first series of experiments, baseline responses of isolated
hearts derived from BK+/+ and BK2/2 mice to I/R (CTRL) were
analyzed (Fig. 4A and Table S1 in File S1). Infarct sizes of BK+/+
and BK2/2 hearts subjected to 33 min ischemia and 60 min
reperfusion were not different. Similarly, coronary flow rates,
perfusate volume and heart rates (Fig. 4B and C) measured at
reperfusion were similar between both genotypes indicating that
mitoBK channels per se do not affect myocardial survival or
function upon a prolonged ischemic insult. In the next series of
experiments, BK+/+ and BK2/2 hearts were primed with two,
transient periods of ischemia and reperfusion prior to the
prolonged ischemia (Fig. 4A). Infarct size at I/R was significantly
lower in BK+/+ hearts as compared to infarct size in BK2/2 hearts
upon IP (IP BK+/+ 2863% versus IP BK2/2 5865% infarct size
of the area at risk (AAR), n = 5, **P,0.01) (Fig. 4D). Interestingly,
BK ablation fully abrogated beneficial effects of the IP supporting
the presented molecular, electrophysiological, pharmacological
(Fig. 1A–D) and biochemical conclusions (Fig. 2 and 3) that
KCNMA1 encoded cardiac BK channels i.e. mitoBKs are
targeted by survival pathways at I/R injury [47]. In addition to
differences in infarct sizes, coronary flow at reperfusion was
improved by IP in the BK+/+ hearts, but not in BK2/2 hearts
(Fig. 4B). In particular, the perfusate volume used by the BK+/+
hearts towards the end of reperfusion, in two time intervals from
30 to 45 min and from 45 to 60 min, was significantly higher in
cardiac preparation subjected to IP. Several studies did observe an
increase of the post-ischemic coronary flow upon protective IP
associated with smaller infarct size [26,50].
Taken together, our data from the isolated perfused heart model
shows that cardio-protective effects of IP depend on cardiac BK
channel.
Discussion
mitoBK channels are the product of the KCNMA1 gene in
cardiomyocytes
Since the first reports on cardio-protective ‘‘mitoBK channel-
like proteins’’ [15,51] it has been questioned whether mitoBKs are
indeed a product of the KCNMA1 gene, and if they share
identical features with canonical BK channels usually found at the
plasma membrane of SMCs, neurons and endocrine cells [52]. We
support very recent findings [47] showing that an approx.
120 kDa protein in the IMM is identical to the mitoBK channel
derived from KCNMA1 in CMs. Singh et al. [47] detected several
splice-variants and an insertless BK mRNA in murine CMs. By an
elegant set of experiments the authors further confirmed that only
the most abundant CM BK variant DEC with a C-terminal
extension of 50-aa (named after the last 3 aa of the insert), was
targeted efficiently to mitochondria [47]. Herein, we add several
new aspects: 1.) mitoBK is a paxilline- and NS11021-sensitive BK
channel with an open-probability of 0.79 at +80 mV and a slope
conductance of approximately 190 pS, 2.) mitoBKs are important
for full capacity of OXPHOS and the ETS under oxygenated and
anoxic conditions, 3.) lack of mitoBK stimulates ROS production
upon anoxia with subsequent re-oxygenation, and 4.) protection
afforded by IP (in addition to NS1619 [47]) requires the mitoBK.
Altered oxidative energy supply and ROS production in
BK-negative permeabilized muscle fibres and
cardiomyocyte mitochondria
The mitochondrial O2-respirometry experiments performed on
BK2/2 heart muscle fibres reveal that OXPHOS capacity with
substrate supply to both CI and II of the ETS were proportion-
ately attenuated (Fig. 2). The similar substrate control ratio
(BK2/2 (0.3560.01) and BK+/+ (0.3460.03) for CI/CI+CII)
indicates a functional deficit in maximal cellular oxidative energy
supply. Convergent electron input to CI and II (Fig. 2B), which is
the physiologically relevant maximal coupled mitochondrial
respiration, elicited higher respiratory values as compared to the
isolated respiration of CI in both genotypes (Fig. 2A). Interestingly,
brief and prolonged periods of anoxia interfered with the recovery
of the OXPHOS capacity upon re-oxygenation in BK+/+ and
BK2/2 fibres (Fig. 2B). We are aware of the limitations of this
ex-vivo system because it is unlikely that a single episode of 5 min
anoxia ex-vivo (prior to the prolonged anoxia) adequately elicits IP
triggered cardio-protective pathways as observed in full heart
preparations i.e. those factors that signal to CM mitoBKs (or
vascular BKs). The loss of IP in BK2/2 hearts does not necessarily
stem from the decline in the OXPHOS recovery responses,
because it was observed in BK+/+ and BK2/2 fibres after the
initial 5 min anoxia period. Moreover, our combined ROS and
respirometry measurements (Fig. 3) indicate a mitoBK-dependent
control over mitochondrial ROS generation at re-oxygenation,
whereas ROS production at pre-anoxia (Fig. 3A and B) was not
affected by endogenous lack of BK. Because the co-administration
of ROS scavengers has been shown earlier to attenuate pre-
conditioning-like effects afforded by BK-openers such as NS1619
[53], we conclude that BK at the IMM plays a dual role by
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fine-tuning protective and toxic ROS under limited O2 conditions
and conditions of O2 reintroduction thereby integrating to survival
pathways at I/R. However, neither anoxic episodes ex-vivo, nor
the amount of I/R injury revealed any differences between the two
genotypes with respect to the anoxia-induced decrease in
OXPHOS capacities (Fig. 2B) or infarct size (Fig. 4D). Thus,
differences in the experimental setups of IP at the beating heart
model and anoxia in isolated mitochondria may contribute to
control of mitochondrial ROS formation. It is noteworthy that
mitochondria ex-vivo are remarkably robust, being able to tolerate
a prolonged period of anoxia, with recovery of OXPHOS capacity
to ,80% of pre-anoxia levels (Fig. 2B).
Cardiac BK channels contribute to the protective
signalling afforded by ischemic preconditioning while
lack of mitoBKs causes a functional impairment of the
respiratory chain
BK+/+ and BK2/2 mitochondria are intact with respect to
TEM ultra-structures (Figure S1B in File S1), recovery responses
from anoxia (Fig. 2B) and the lack of a cytochrome c response
(Fig. 2C). The extent of ischemic infarction (in the absence of IP)
in the Langendorff-perfused heart stems from ischemic signalling
events within the myocardium independent of endogenous
mitoBK activity. This is in good agreement with other studies of
I/R injuries in intact heart preparations at baseline [34,35].
However, we and others [47] find mitoBK channels are involved
in the IP-mediated cardio-protection.
This is in accordance with earlier pharmacological studies [28]
with BK channel activators (NS1619, NS11021) applied prior to
ischemia exhibiting significant cardio-protective effects at I/R
[15,26]. Pharmacological activation of the channel depolarizes the
IMM potential and attenuates mitochondrial Ca2+ accumulation
[16], thereby, the mitoBK channels could serve a similar role as in
the plasma-membrane of electrically excitable cells where BK
prevents Ca2+ accumulation. Furthermore, opening of mitoBK
channels has been reported to mildly increase ROS production
during preconditioning, with the formed ROS acting as an
important signaling molecule for triggering pharmacological
preconditioning [18,53]. Similarly, with regards to IP, ROS
formed at IP acts as an important trigger of cardio-protection
[54,55]. Finally, studies have indicated that activating K+-flux
through mitoBKs improves the energetic performance of cardiac
mitochondria, fine-tuning the mitochondrial volume to optimize
oxidative phosphorylation [56]. These findings support our
observations of a reduced functional capacity of OXPHOS and
loss of cardio-protection by IP in BK2/2 hearts. Consistent with
the impaired OXPHOS responses of CI and CI+II under fully
oxygenated conditions, the isolated activity of COX was also
markedly reduced in the BK2/2 ventricular fibres. This indicates
that the absence of the mitoBK channels causes a functional
impairment of sequential components of the respiratory chain as
previously reported [23]. Under physiological conditions COX
excess capacity maintains a high affinity for O2 during coupled
respiration, a low membrane potential, a corresponding low PO2
at cytochrome aa3 and thus a high PO2 gradient from the
capillary to mitochondria facilitating O2 diffusion [57]. The
finding that OXPHOS operates at near maximum COX activity
in BK2/2 suggests a more reduced redox state of COX during
ADP-stimulation respiration [58,59]. In this setting, a higher ROS
production has been reported [59,60], which may alter diverse
signalling pathways and functional characteristics of mitochondria
[57,61] and indeed we find elevated ROS release from BK2/2
mitochondria only upon O2 reintroduction after prolonged anoxia
in vitro.
The finding that a prolonged period of 60 min of anoxia
significantly (and equally) reduced OXPHOS recovery in both
genotypes, but to different absolute levels, further supports the
notion of a loss of key regulatory signals in the BK2/2 hearts
during the IP experiments and points to the different infarct size
between the groups. The functional marker of a higher
OXPHOS:COX respiration ratio in the BK2/2 fibres (0.9 vs.
0.65 BK+/+) indicates a dysregulation of mitochondrial functions
linked to loss of excess capacity of COX independent of density or
volume of the mitochondria. Both Ca2+ and ROS may activate the
BK channel [18], which is thought to control Ca2+ and ROS levels
in mitochondria upon limited O2 or O2 re-introduction, confer-
ring cardio-protection against cellular stress, mitochondria per-
meability pore opening and Bax-mediated pro-apoptotic events
[62]. The combined responses of reduced OXPHOS capacity,
lower COX activity and elevated ROS production from BK2/2
mitochondria suggest a mechanism for loss of cardio-protection by
IP in BK2/2 mice.
Limitations of the presented study
Obviously, our report does not exclude the possibility that the
protection afforded by the IP protocol is also influenced by
vascular BK channels. Differences in infarct size and the parallel
perfusion response following pre-conditioning (Fig. 4B and D)
might indeed reflect a close matching between convective O2
delivery and metabolic demand of the hearts. It is possible that the
differences in perfusion responses between the two genotypes
following IP reflect differences in the mass of viable cells and
subsequently a reduced corresponding O2 demand in the BK
2/2.
Additionally, the metabolic demands of the BK-negative hearts
could be lower due to differences in heart rates in the Langendorff-
perfused heart model (Fig. 4C). BK channel activity in coronary
smooth muscle cells (SMCs) or elsewhere could contribute to
vasodilation in BK+/+ and consequently to changes in hemody-
namics. Alternatively, the ischemia may induce overlapping vaso-
regulatory signals that may be independent of the O2 demand of
the myocardium. Direct vascular effects due to opening of SMC
BK channel upon reperfusion are unlikely since BK2/2 hearts
show a strongly preserved reactive hyperemic response upon a
transient 5 min ischemia, an uncompromised baseline coronary
flow (Figure S4 in File S1), and the improvement in myocardial
functions observed with the BK openers NS1619 [47] or NS11021
were independent of significant increases in flow [26].
Conditional and inducible KCNMA1 mutant mouse models
lacking the BK exclusively in SMCs, platelets, intrinsic cardiac
neurons or cardiomyocytes are urgently needed to discriminate
these details in vivo [35,63,64].
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